Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deep learning and multi-omics approach to predict drug responses in cancer.

BMC bioinformatics - 28 Nov 2022

Wang Conghao, Lye Xintong, Kaalia Rama, Kumar Parvin, Rajapakse Jagath C

Abstract excerpt

BACKGROUND: Cancers are genetically heterogeneous, so anticancer drugs show varying degrees of effectiveness on patients due to their differing genetic profiles. Knowing patient's responses to numerous cancer drugs are needed for personalized treatment for cancer. By using molecular profiles of cancer cell lines available from Cancer Cell Line Encyclopedia (CCLE) and anticancer drug responses available in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deep Learning
Share to DNA Copy Number Variations
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36443676
DOI: 10.1186/s12859-022-04964-9
PMCID: PMC9703655

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deep learning and multi-omics approach to predict drug responses in cancer.PMID 36443676Read ↗

BKDRP: A Biological Knowledge-Driven Approach for Drug Response Prediction Using Multi-Omics Data in Cancer Cell LinesSemantic proximity Read ↗

MOLI: Multi-Omics Late Integration with deep neural networks for drug response predictionSemantic proximity Read ↗

DeepCDR: a hybrid graph convolutional network for predicting cancer drug responseSemantic proximity Read ↗

Gene-centric multi-omics integration with convolutional encoders for cancer drug response predictionSemantic proximity Read ↗

Looking at the BiG picture: Incorporating bipartite graphs in drug response predictionSemantic proximity Read ↗

DROEG: a method for cancer drug response prediction based on omics and essential genes integrationSemantic proximity Read ↗

An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response PredictionSemantic proximity Read ↗

drGAT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous NetworkSemantic proximity Read ↗

Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.Semantic proximity Read ↗

Drug Response Prediction and Biomarker Discovery Using Multi-Modal Deep LearningSemantic proximity Read ↗

A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsSemantic proximity Read ↗

Multi-omics and deep learning provide a multifaceted view of cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.